Overview

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2026-07-08

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to learn about the safety profile of niraparib in adult female participants for the treatment of advanced or relapsed epithelial ovarian cancer.

Phase:

PHASE4

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

niraparib